Clinical Research Program
This is a list of clinical trials and research protocols underway that will help us study thryoid malignancies and other endocrine neoplasias. If you would like to participate in one of the trials, please call the Information Line toll-free at 1-800-392-1611 or askMDAnderson at 1-877-632-6789. For information on other clinical trials, please visit MD Anderson's Clinical Trials Web site.
- Thyroid Cancer
- Pituitary Tumors
- Other Endocrine Neoplasias including solid tumors
- Other MD Anderson Clinical Trials relevant to Endocrine Neoplasia patients
A Phase II trial using RAD001 for patients with radioiodine refractory thyroid cancer.
The goal of this clinical research study is to learn if RAD001 can help to control locally-advanced or metastatic thyroid cancer.
A Pharmacodynamic study of vemurafenib in the neoadjuvant setting in patients with locally advanced thyroid cancer.
The goal of this clinical research study is to learn about how vemurafenib may affect certain biomarkers in patients with papillary thyroid cancer.
ACROSTUDY - A Multicenter, Post Marketing Surveillance Study of Somavert Therapy in Patients with Acromegaly in the US and Europe.
The goal of this clinical research study is to look at the safety and effectiveness of long-term pegvisomant treatment for acromegaly
A Phase II Study of Pazopanib (GW786034) in Patients with Advanced and Progressive Malignant Pheochromocytoma or Paraganglioma
The goal of this clinical research study is to learn if Votrient (pazopanib) can help to control metastatic pheochromocytoma or paraganglioma.
A Single-Arm, Multicenter, Proof-of-concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects with Elevated Serum Calcium Despite Recent Treatment with IV Bisphosphonates.
The goal of this clinical research study is to learn if denosumab can help to control hypercalcemia in patients with cancer.
Last Updated: April 8, 2013
The Rolanette and Berdon Lawrence Bone Disease Program of Texas
The Rolanette and Berdon Lawrence Bone Disease Program of Texas utilizes the high quality research and clinical programs of MD Anderson Cancer Center and Baylor College of Medicine to improve early and more accurate diagnosis, treatment and prevention of bone diseases such as osteoporosis and bone metastases afflicting the people of Texas.